Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Fluid volume represents the total quantity of fluid within the body's physiological compartments, specifically the extracellular fluid (ECF) and intravascular plasma volume (StatPearls, 2023). It is not a single molecular target but rather a physiological state regulated by a network of receptors, transporters, and hormones, including the renin-angiotensin-aldosterone system (RAAS) and natriuretic peptides (NIH, 2022). Maintaining fluid volume is essential for hemodynamic stability, tissue perfusion, and electrolyte balance (StatPearls, 2023). In clinical practice, fluid volume is managed through pharmacological agents like diuretics, which target specific renal transporters (e.g., NKCC2, NCC) to promote water and salt excretion, or through intravenous fluids to address depletion (StatPearls, 2024). Pathological alterations in fluid volume are central to the pathophysiology of conditions such as congestive heart failure, cirrhosis, and chronic kidney disease, where volume overload occurs, as well as dehydration and shock, which involve volume depletion (NIH, 2022). Monitoring fluid status often involves clinical biomarkers such as B-type natriuretic peptide (BNP) and physical assessments like weight changes or central venous pressure (PubMed, 2021). Therapeutic strategies aim to modulate the underlying molecular mechanisms to achieve euvolemia and prevent complications like pulmonary edema or organ hypoperfusion (StatPearls, 2023).
Drugs modulate fluid volume by inhibiting renal ion transporters, antagonizing hormonal receptors (e.g., V2, MR), or altering osmotic/oncotic pressure to regulate sodium and water homeostasis (StatPearls, 2024).
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Fluid volume (Extracellular fluid volume) (ECFV).